[Cardioprotective effect of aldosterone antagonists for ventricular remodeling].
Tatsumi
Tetsuya
T
Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine.
Matsubara
Hiroaki
H
D000450:Aldosterone / Q000502:physiology*; D000818:Animals; D002986:Clinical Trials as Topic; D000077545:Eplerenone; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology* / Q000517:prevention & control; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000494:pharmacology* / Q000627:therapeutic use*; D017382:Reactive Oxygen Species / Q000378:metabolism; D018161:Receptors, Mineralocorticoid / Q000502:physiology; D013148:Spironolactone / Q000031:analogs & derivatives / Q000627:therapeutic use; D020257:Ventricular Remodeling / Q000187:drug effects*
D000451:Mineralocorticoid Receptor Antagonists; D017382:Reactive Oxygen Species; D018161:Receptors, Mineralocorticoid; D013148:Spironolactone; D000450:Aldosterone; D000077545:Eplerenone